Seattle Genetics Inc. and Takeda Pharmaceutical Co have developed a new drug for cancer which work like a guided missile. The drug SGN-35 is a combination of a cancer-seeking antibody with a tumor-killing chemical. It has cleared cancer to undetectable levels in 53 percents with anaplastic large cell lymphoma, and also cut tumor size by at least half in another 33 percent. The antibody guides the drug to cancerous cells at very high concentrations thus it prevent the drug from entering the bloodstream or affecting healthy tissues.
Source: Businessweek